Metabolic risk assessment of Indian women with polycystic ovarian syndrome in relation to four Rotterdam criteria based phenotypes

被引:18
|
作者
Tripathy, Priyadarshini [1 ]
Sahu, Asutosh [2 ]
Sahu, Mahija [1 ]
Nagy, Attila [3 ]
机构
[1] SCB Med Coll, Dept Obstet & Gynecol, Cuttack 753007, Odisha, India
[2] SCB Med Coll, Dept Radiodiag, Cuttack, Odisha, India
[3] Univ Debrecen, Fac Publ Hlth, Dept Prevent Med, Debrecen, Hungary
关键词
Hyperandrogenism; Metabolic syndrome; Obesity; PCOS; Rotterdam phenotypes; ENDOCRINE CHARACTERISTICS; INSULIN-RESISTANCE; PREVALENCE;
D O I
10.1016/j.ejogrb.2018.02.031
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objectives: Though polycystic ovarian syndrome (PCOS) is associated with multiple metabolic abnormalities, the metabolic risk profile of various PCOS phenotypes is still debated. Here we sought to compare the clinical, biochemical and metabolic parameters among the different PCOS phenotypes and controls. Study design: A total of 394 newly diagnosed PCOS women and 108 controls were enrolled consecutively. PCOS women were divided into four phenotypes based on the presence of two of the following Rotterdam criteria: oligo/anovulation (O), hyperandrogemsm (H), and polycystic ovaries (P): A (O + H + P), B (O + H), C (H + P), D (O + P). Results: Phenotype A (55.8%) was the most common phenotype in the PCOS cohort. Prevalence of metabolic syndrome was highest in phenotype A and B compared to other two phenotypes and controls. The clinical, biochemical and metabolic characteristics, of phenotypes A and B, were similar, but phenotype A had higher hirsutism score and androgen level. Phenotype C had intermediate metabolic characteristics between A and controls whereas phenotype D had the mildest metabolic abnormalities among the four phenotypes. Significant predictors for metabolic syndrome within the PCOS cohort are waist circumference >80 cm, hypertension, fasting glucose >100 mg/dL, HDL-cholesterol <50 mg/dL and triglyceride >150 mg/dL (p < 0.001). Conclusions: Indian PCOS women with Phenotype A and B he at increased metabolic risk compared to other phenotypes. Phenotypic classification of PCOS women may facilitate more effective application of screening and treatment strategies for high-risk metabolic phenotypes. (C) 2018 Elsevier B.V. All rights reserved.
引用
收藏
页码:60 / 65
页数:6
相关论文
共 50 条
  • [31] Assessment of Risk Factors of Polycystic Ovarian Syndrome Among Women: An Online Based Survey
    Ishrar, S. M. G.
    Narayana, Goruntla
    Aneesa, K. S. Asma
    Priya, Chennampalli
    Swetha, Roddam
    INTERNATIONAL JOURNAL OF LIFE SCIENCE AND PHARMA RESEARCH, 2023, 13 (03): : P10 - P16
  • [32] Serum fatty acid profiles associated with metabolic risk in women with polycystic ovary syndrome
    Tian, Ye
    Zhang, Jingjing
    Li, Mingyue
    Shang, Jie
    Bai, Xiaohong
    Zhang, Huijuan
    Wang, Yanxia
    Chen, Haitao
    Song, Xueru
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [33] Elevated fasting insulin is associated with cardiovascular and metabolic risk in women with polycystic ovary syndrome
    Rasool, Shayaq Ul Abeer
    Ashraf, Sairish
    Nabi, Mudasar
    Rashid, Fouzia
    Fazili, Khalid Majid
    Amin, Shajrul
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2019, 13 (03) : 2098 - 2105
  • [34] Effect of metformin on the clinical and metabolic assessment of women with polycystic ovary syndrome
    Santana, LF
    de Sá, MFS
    Ferriani, RA
    de Moura, MD
    Foss, MC
    dos Reis, RM
    GYNECOLOGICAL ENDOCRINOLOGY, 2004, 19 (02) : 88 - 96
  • [35] Non-alcoholic fatty liver disease in polycystic ovarian syndrome in Indian women
    Siwatch, Sujata
    Singh, Virendra
    Dhaliwal, Lakhbir K.
    Kumari, Sunita
    Singh, Kartar
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2022, 42 (05) : 957 - 961
  • [36] Prevalence of Polycystic Ovary Syndrome Phenotypes Using Updated Criteria for Polycystic Ovarian Morphology: An Assessment of Over 100 Consecutive Women Self-reporting Features of Polycystic Ovary Syndrome
    Nina M. Clark
    Amanda J. Podolski
    Eric D. Brooks
    Donna R. Chizen
    Roger A. Pierson
    Denis C. Lehotay
    Marla E. Lujan
    Reproductive Sciences, 2014, 21 : 1034 - 1043
  • [37] Preventing endometrial cancer risk in polycystic ovarian syndrome (PCOS) women: Could metformin help?
    Shafiee, Mohamad Nasir
    Khan, Gulafshana
    Ariffin, Rina
    Abu, Jafaru
    Chapman, Caroline
    Deen, Suha
    Nunns, David
    Barrett, David A.
    Seedhouse, Claire
    Atiomo, William
    GYNECOLOGIC ONCOLOGY, 2014, 132 (01) : 248 - 253
  • [38] Effect of Junk Food on Hormonal and Metabolic Manifestations in Polycystic Ovarian Syndrome Phenotypes: A Case-Control Study of Kashmiri Population
    Nisa, Khair Ul
    Tarfeen, Najeebul
    Mir, Shahnaz Ahmad
    Khurshid, Zulaykha
    Ahmad, Mir Bilal
    Wani, Saba
    Bhat, Humaira
    Ganai, Bashir Ahmad
    INDIAN JOURNAL OF CLINICAL BIOCHEMISTRY, 2025, 40 (02) : 218 - 232
  • [39] Associations of Birthweight and Gestational Age with Reproductive and Metabolic Phenotypes in Women with Polycystic Ovarian Syndrome and Their First-Degree Relatives
    Legro, Richard S.
    Roller, Rebecca L.
    Dodson, William C.
    Stetter, Christina M.
    Kunselman, Allen R.
    Dunaif, Andrea
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2010, 95 (02) : 789 - 799
  • [40] Endocrine and metabolic characteristics of polycystic ovary syndrome in Chinese women with different phenotypes
    Xu, Xinghua
    Shi, Yuhua
    Cui, Yuqian
    Ma, Jinlong
    Che, Li
    Chen, Zi-Jiang
    CLINICAL ENDOCRINOLOGY, 2012, 76 (03) : 425 - 430